Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
- P. Kantoff, C. Higano, P. Schellhammer
- MedicineThe New England journal of medicine
- 23 July 2010
TLDR
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
- D. Petrylak, C. Tangen, E. Crawford
- MedicineThe New England journal of medicine
- 7 October 2004
TLDR
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
- H. Scher, S. Halabi, M. Hussain
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 March 2008
TLDR
Abiraterone in metastatic prostate cancer without previous chemotherapy.
- C. Ryan, Matthew R. Smith, D. Rathkopf
- MedicineThe New England journal of medicine
- 9 January 2013
TLDR
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
- E. Small, P. Schellhammer, R. Hershberg
- MedicineJournal of clinical oncology : official journal…
- 1 July 2006
TLDR
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
- J. Mohler, E. Antonarakis, Deborah A. Freedman-Cass
- Medicine, BiologyJournal of the National Comprehensive Cancer…
- 1 May 2019
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced…
Apalutamide Treatment and Metastasis‐free Survival in Prostate Cancer
- Matthew R. Smith, F. Saad, E. Small
- MedicineThe New England journal of medicine
- 8 February 2018
TLDR
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.
- B. Rini, S. Halabi, E. Small
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 May 2010
TLDR
Prostate Cancer, Version 1.2016.
- J. Mohler, A. Armstrong, Deborah A. Freedman-Cass
- MedicineJournal of the National Comprehensive Cancer…
- 2016
TLDR
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.
- G. Bubley, M. Carducci, G. Wilding
- MedicineJournal of clinical oncology : official journal…
- 1 November 1999
TLDR
...
1
2
3
4
5
...